- Open Access
Treatment with TNF-α or bacterial lipopolysaccharide attenuates endocardial endothelial cell-mediated stimulation of cardiac fibroblasts
Journal of Biomedical Science volume 16, Article number: 21 (2009)
The endocardial endothelium that lines the inner cavity of the heart is distinct from the microvascular endothelial cells and modulates cardiac muscle performance in a manner similar to the vascular endothelial modulation of vascular structure and vasomotor tone. Although the modulatory effects of endocardial endothelium (EE) on cardiomyocytes are firmly established, the regulatory effects of endocardial endothelium on the cardiac interstitium and its cellular components remain ill defined.
Methods and Results
We investigated whether the stimulatory effect of EE on cardiac fibroblasts would be altered when EECs are activated by the cytokine tumor necrosis factor-α (TNF-α) or the endotoxin bacterial lipopolysaccharide (LPS). Both TNF-α and LPS were found to independently attenuate the stimulatory effect of EE on cardiac fibroblasts. These agents lowered the synthesis or release of ET-1 and increased the secretion of TGF-β and NO.
The findings of this study using endocardial endothelial cells (EECs) and neonatal cardiac fibroblasts demonstrate that pro-inflammatory cytokines cause altered secretion of paracrine factors by EECs and inhibit proliferation and lower collagen synthesis in fibroblasts. These changes may influence fibroblast response and extra cellular matrix remodeling in pathological conditions of the heart.
The endocardial endothelium (EE) that lines the inner cavity of the heart is distinct from the microvascular endothelial cells in terms of embryological origin, cytoskeletal organization, receptor – mediated functions, electrophysiological properties, release of prostanoids and growth characteristics in culture . The EE is strategically situated between the circulating blood and the cardiac muscle and it modulates cardiac muscle performance exactly as the vascular endothelium modulates vascular structure and vasomotor tone. Brutsaert et al  have demonstrated that EE is an important modulator of subjacent cardiac muscle performance. Dysfunction of this interface could be a critical factor in various pathological conditions of the heart. Evidence of physiologically significant paracrine interactions between the endocardial cell populations and muscle cells of the heart accrued from studies on factors of endothelial origin such as endothelins, angiotensin II, nitric oxide (NO), natriuretic peptides, bradykinin prostaglandins, adenylpurines, myofilament desensitizing element and enzymes such as angiotensin converting enzyme and kininase. Importantly, an imbalance in the turnover of these factors in cardiovascular diseases may potentially promote alterations in the extra cellular matrix (ECM) and disturb cardiomyocyte function. In fact, heart function is reported to be significantly affected by increased cytokine production in a setting of endotoxic shock, transplant rejection and ischemia/reperfusion . Endothelium derived factors such as TNF-α, IL-1β, IL-6 and TGF-β may exert autocrine and paracrine effects on fibroblast growth and collagen turnover as well.
Whereas the modulatory influence of EE on cardiomyocytes is well established, the effects of EE on the cardiac interstitium and its cellular components particularly the fibroblasts, which maintain the extracellular matrix homeostasis are far less defined . In this regard, we had recently reported a significant increase in cardiac fibroblast proliferation and collagen synthesis when the cells are grown in EEC conditioned media . In the present study, we investigated whether the stimulatory effect of EE on cardiac fibroblasts would be altered in conditions where TNF-α or the endotoxin bacterial LPS activates EECs. Our results suggest that TNF-α or LPS – activated EE cells attenuate proliferation and collagen synthesis in cardiac fibroblasts.
Materials and methods
Tissue culture media and all supplements were procured from Sigma-Aldrich, St. Louis, USA. [3H]-Thymidine and [3H]-Proline was obtained from Board of Radioactivity and Isotope Technology (BRIT), Mumbai, India. DiI-Acetylated LDL was purchased from Molecular Probes, Netherlands.
Preparation of cultures of endocardial endothelial cells
Endocardial endothelial cells were isolated from freshly collected pig hearts by the method previously described by Smith et al . Briefly, the ventricles were filled with 0.1% collagenase (Type IA) in medium E199 and incubated for 45 minutes. The released cells were resuspended in complete medium (medium E199 supplemented with 20% fetal bovine serum (FBS), 1% endothelial cell growth factor, 100 U/ml benzyl penicillin and 100 μg/ml streptomycin) and seeded in gelatin – coated culture dishes. Confluent cultures were sub – cultured using 0.025% trypsin – 0.02% EDTA. The cells were identified as endothelial cells by their cobblestone appearance, positive staining for factor VIII antigen and incorporation of DiI-acetylated low-density lipoproteins.
Preparation of cultures of cardiac fibroblasts
Cardiac fibroblasts were isolated from 3- to 4-day-old Wistar rat pups. The heart tissue was minced and digested with 0.03 % collagenase and 0.03 % trypsin. The supernatants were centrifuged and cell pellet was resuspended in medium M199 with 10% FBS. Cardiac fibroblasts attached within 90 minutes. The cells were grown to confluence and passaged with 0.025% trypsin-0.02% EDTA mixture. The cells were identified as fibroblasts by their spindle morphology, positive staining for vimentin and negative staining for factor VIII antigen.
All experiments had the approval of the Institutional Animal Ethics Committee.
Preparation of conditioned medium
The experiments were performed on EECs from the 3rd – 4th passages. Cells were seeded at a density of 2 × 105 cells/ml in 35 mm culture dishes. At confluence, the cells were made quiescent by reducing the serum content of the medium to 0.4% for 24 hours. On the day of the experiment, the cells were washed with phosphate – buffered saline and treated with either 10 ng/ml TNF-α or 1 μg/ml bacterial LPS. Cells incubated in 0.4% FBS containing medium served as control. At the end of the incubation period of 24 hours, the medium was collected, centrifuged to remove cellular debris and stored at -80°C until use. Dulbecco's modified Eagle's medium (DMEM) was used for generating conditioned medium for the collagen synthesis experiments.
DNA synthesis in cardiac fibroblasts was measured in terms of [3H]-Thymidine incorporation into DNA (n = 15) as described earlier . Cells were seeded at a density of 1 × 105 cells/ml and incubated for 24 hours. Cells from passage 2 were made quiescent by incubating them in medium containing 0.4% FBS for 24 hours. Following incubation of the cells with [3H]-Thymidine at a final concentration of 1 μCi/ml for 24 hours, acid – insoluble radioactivity was determined by using liquid scintillation spectrometry.
Collagen synthesis assay
Incorporation of [3H]-Proline by cardiac fibroblasts was taken as a measure of collagen synthesis (n = 9). Cardiac fibroblasts at confluence were incubated in DMEM supplemented with 0.4% FBS, 24 hours prior to treatment. Subsequently, cells were incubated for 24 hours in either 0.4% FBS or EEC – conditioned medium, containing 2 μCi/ml [3H]-Proline and 50 μg/ml ascorbic acid in DMEM. The supernatant was collected and cells were lysed using 1% Triton-X 100 containing 5 mM N-ethylmaleimide. The cell lysate and medium were pooled and the mixture divided into two aliquots. Proteins in one aliquot were precipitated with 10% ice-cold TCA. The second aliquot was digested with 30 μg/ml collagenase Type VII in Tris-CaCl2 buffer (pH – 7.4) for 5 hours at 37°C. At the end of collagenase digestion, the proteins were precipitated with 10% ice-cold TCA. The TCA-precipitated material in the two aliquots was filtered separately onto Whatman no.3 filter paper. Radioactivity was determined using a scintillation counter. Collagen synthesis was calculated using the equation:
A correction factor of f = 5.4 for non-collagen protein was used to adjust for the relative abundance of proline and hydroxyproline in collagen containing proteins .
Measurement of EEC – derived factors in the conditioned medium
The conditioned medium was assayed (n = 6) for the levels of EEC – derived factors, ET-1 (Cayman Chemical, MI, USA), Ang II (SPI BIO, France) and TGF-β1 (Biosource International, Belgium) by ELISA using commercially available kits.
Sample means were compared using Student's t-test. ANOVA was employed for group comparisons where there were more than two groups. The values are expressed as mean ± SD. p < 0.05 was considered statistically significant.
Effect of TNF-α and LPS on EEC-induced proliferation of cardiac fibroblasts
On incubation with EE – conditioned medium, [3H]-Thymidine incorporation into cardiac fibroblast DNA increased by 22%. The stimulatory effect was however attenuated when cardiac fibroblasts were incubated in medium conditioned by TNF-α or LPS treated EECs. [3H]-Thymidine counts per minute (cpm) with medium conditioned by untreated EECs was 49678 ± 418.7. [3H]-Thymidine counts per minute (cpm) with medium conditioned by EECs treated with TNF-α or LPS were 45271.7 ± 1008.7 cpm and 45163.6 ± 802.5 cpm respectively. The basal [3H]-Thymidine counts per minute (cpm) with 0.4% M199 was 40676 ± 985 cpm. Thus, TNF-α treated EECs attenuated [3H]-Thymidine incorporation into DNA of cardiac fibroblasts by 11.3 % (n = 15; p < 0.01) and LPS treated EECs attenuated [3H]-Thymidine incorporation into DNA of cardiac fibroblasts by 11% (n = 15; p < 0.01) (Figure 1).
Effect of TNF-α and LPS on EEC-induced collagen synthesis by cardiac fibroblasts
The effect of medium conditioned by TNF-α or LPS treated EECs, on collagen synthesis by cardiac fibroblasts is shown in Figure 2. The basal rate of collagen synthesis by cardiac fibroblasts in 0.4% M199 was 6.51 ± 1.0 % of the total protien and by fibroblasts grown in medium conditioned by untreated EECs was 10.6 ± 0.9 % of the total protien. Collagen synthesis by cardiac fibroblasts was reduced to 4.85 ± 0.9 % and 5.12 ± 1 % of the total protein respectively when the cells were grown in medium conditioned by TNF-α or LPS treated EECs (n = 6; Control-CM vs TNF-CM and LPS-CM, p < 0.05). Whereas a 6 % increase in collagen synthesis was seen in fibroblasts grown in medium conditioned by untreated EECs, rate of collagen synthesis in cardiac fibroblasts incubated with conditioned medium from EECs treated with TNF-α or LPS was seen to decrease by 25% and 21% respectively, compared to the control (Figure 2).
Assay of endocardial endothelial cell released factors in the culture supernatants
Levels of endothelium-derived factors ET-1, AII, and TGF-β1, were determined by ELISA according to the manufacturer's protocols. NO released into the medium was measured as nitrite by Griess reaction.
Treatment of EECs with TNF-α and LPS caused increased release of nitrite from the cells into the culture supernatant. The amount of nitrite released into the medium conditioned by untreated EECs was 1.81 ± 0.17 μM. TNF-α or LPS treatment of EECs increased nitrite levels in the culture supernatant to 2.86 ± 0.29 μM and 4.48 ± 0.44 μM respectively (n = 6; p < 0.05). Thus, stimulation of EECs with TNF-α or LPS increased nitrite release from EECs by 58% and 147% respectively (Figure 3).
ET-1 levels and TGF-β levels in the culture supernatant of EECs treated with TNF-α were 5.56 ± 0.02 ng/ml and 7.21 ± 0.1 ng/ml respectively compared to ET -1 and TGF-β levels of 6.6 ± 0.01 ng/ml and 6.56 ± 0.05 ng/ml respectively in the culture supernatant of untreated EECs (n = 6; p < 0.01). Thus, TNF-α depressed the release of ET-1 by 16% but increased TGF-β release by 10% from EECs.
When EECs were treated with LPS, the ET-1 levels in the culture supernatant was 6.1 ± 0.03 ng/ml and TGF-β levels were 5.66 ± 0.08 ng/ml compared to the ET-1 levels of 6.63 ± 0.01 ng/ml and TGF-β levels of 6.56 ± 0.05 ng/ml in the culture supernatant of untreated EECs (n = 6; p < 0.01). Thus, treatment of EECs with LPS reduced ET-1 secretion by 8% and TGF-β secretion by 13.7% (Figures 4 and 5).
Angiotensin II levels were undetectable in all the culture supernatants.
It is well recognized that vascular endothelial cells exert marked regulatory influence on subjacent non-endothelial cells such as myocytes, fibroblasts, pericytes and smooth muscle cells (SMCs) [9–13]. Given the regional differences in the functional properties of the endothelium, we had earlier investigated the role of EE in modulating cardiac fibroblast proliferation and collagen synthesis and found that EE has a stimulatory effect on cardiac fibroblasts . In the present study we explored whether pro – inflammatory agents such as TNF-α and LPS modulate this stimulatory effect. Interestingly, both TNF-α and LPS were found to attenuate the stimulatory effect of EE on cardiac fibroblasts.
The inflammatory effects of TNF-α and LPS on vascular endothelial cells are well – characterized. Endothelial cells obtained from different sites exhibit varied responses to cytokines and LPS . However, the effects of TNF-α and LPS on endocardial endothelial cells have not been previously reported.
In the present study, [3H]-Thymidine incorporation as well as rate of collagen synthesis were significantly lower in cardiac fibroblasts grown in conditioned medium from EECs treated with either TNF-α or LPS, when compared to the cells grown in EEC conditioned medium and not treated with either agents. Neither TNF-α nor LPS affected the viability of the cells. Concentrations of TNF-α up to 1000 ng/ml have been reported to cause reduction in collagen synthesis in cardiac fibroblasts without affecting the cell numbers . Our study demonstrated not only the direct inhibitory action of TNF-α on collagen synthesis in cardiac fibroblasts, but also its ability to attenuate the stimulatory effect of EECs on collagen production by cardiac fibroblasts. Yokoyama et al  proposed that TNF-α could act as an autocrine/paracrine mediator in myocardial remodeling. The cytokine increases both the expression and activity of matrix metalloproteinases (MMPs) which regulate matrix turnover . In studies investigating the direct effect of TNF-α on cardiac fibroblasts, it has been observed that the cytokine decreases total collagen synthesis [18, 19].
We also observed alterations in the release of endothelium-derived factors, such as NO, TGF-β and ET-1 into the conditioned medium when EECs were treated with TNF-a or LPS, which in turn could contribute to the altered response elicited in cardiac fibroblasts treated with the conditioned medium. EECs released significantly higher levels of nitrite in response to the pro-inflammatory agents. A notable action of TNF-α is its ability to induce nitric oxide synthase (NOS) activity in different cell types, including endocardial cells [6, 20]. Nitric oxide (NO) is an important modulator of TNF-α in the heart. In addition to being an immunomodulator and a potent inhibitor of platelet aggregation and cell migration, NO is also an anti-mitogen [21–23]. In a study using endothelial cells and SMCs from coronary arteries, inhibition of NO has been shown to cause an increase in the concentration of collagen types I and III. The data also supports an inhibitory role for NO on collagen synthesis . Extrapolating these findings to the present study, it is tempting to postulate that the attenuation of the proliferative response in cardiac fibroblasts is the result of increased release of NO from EECs on treatment with TNF-α or LPS.
Levels of endothelin (ET-1) in the conditioned medium from EECs treated with TNF-∝ or LPS were found to be lower, raising the possibility that a decrease in the levels of ET-1 may contribute to the diminished proliferative response in fibroblasts. Our earlier studies using endothelin inhibitors had shown that the stimulatory effect of EECs on cardiac fibroblasts is mediated by ET-1 .
Treatment of EECs with TNF-∝ also resulted in an elevation of TGF-β in the conditioned medium. Dose-dependent increase in TGF-β release has been observed in microglial cells treated with TNF-∝ . It is possible that TNF-∝ may regulate TGF-β expression as a feed back mechanism to limit extra cellular degradation in response to injury. TGF-β being inhibitory to cardiac fibroblast proliferation, the increased levels of this peptide in the conditioned medium from TNF-∝ treated EECs obviously accentuates the attenuation of proliferation brought about by increased NO and decreased ET-1.
LPS causes cardiac dysfunction by enhancing cardiac-derived inflammatory mediator expression, associated with the release of pro-inflammatory cytokines such as TNF-α and IL-1β and over production of NO [26, 27]. Human coronary endothelial cells stimulated with LPS express higher levels of TNF mRNA and release increased levels of the cytokine . Since most of the effects of LPS are through TNF, it can be assumed that in cardiac fibroblasts, the endotoxin elicits responses similar to that induced by TNF-α.
In this study, we have explored the independent effects of TNF-α and LPS on fibroblast function mediated through major mediators released by EECs. It is possible that other EE-derived mediators are also involved in the modulation of fibroblast growth and collagen synthesis. A limitation of the study is the usage of cells from two different species, but in previous studies on the interaction of endothelial cells with their neighboring cells, others have also employed cells derived from different species .
This study suggests that pro-inflammatory cytokines can cause altered expression of paracrine factors in EECs, that in turn may inhibit proliferation and lower collagen synthesis in cardiac fibroblasts. The effects of TNF-α or LPS on EECs as observed in our study may be of significance in pathological conditions such as cardiac failure and during post inflammatory wound healing where different cytokines are up – regulated in the tissues.
Shah AM: Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res. 1996, 31 (6): 847-867.
Brutsaert DL, Meulemans AL, Sipido KR, Sys SU: Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res. 1988, 62 (2): 358-366.
Palmer JN, Hartogensis WE, Patten M, Fortuin FD, Long CS: Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest. 1995, 95 (6): 2555-2564. 10.1172/JCI117956.
Andries LJ, Sys SU, Brutsaert DL: Morphoregulatory interactions of endocardial endothelium and extracellular material in the heart. Herz. 1995, 20 (2): 135-145.
Kuruvilla L, Nair RR, Umashankar PR, Lal AV, Kartha CC: Endocardial endothelial cells stimulate proliferation and collagen synthesis of cardiac fibroblasts. Cell Biochem Biophys. 2007, 47 (1): 65-72.
Smith JA, Radomski MW, Schulz R, Moncada S, Lewis MJ: Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase. Br J Pharmacol. 1993, 108 (4): 1107-1110.
Tan LB, Jalil JE, Pick R, Janicki JS, Weber KT: Cardiac myocyte necrosis induced by angiotensin II. Circ Res. 1991, 9 (5): 1185-1195.
Diegelmann RF, Peterkofsky B: Collagen biosynthesis during connective tissue development in chick embryo. Dev Biol. 1972, 28 (3): 443-453. 10.1016/0012-1606(72)90028-0.
Baird A, Ling N: Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Commun. 1987, 142 (2): 428-435. 10.1016/0006-291X(87)90292-0.
Gajdusek C, DiCorleto P, Ross R, Schwartz SM: An endothelial cell-derived growth factor. J Cell Biol. 1980, 85 (2): 467-472. 10.1083/jcb.85.2.467.
Gajdusek CM, Schwartz SM: Ability of endothelial cells to condition culture medium. J Cell Physiol. 1982, 110 (1): 35-42. 10.1002/jcp.1041100107.
Guarda E, Myers PR, Brilla CG, Tyagi SC, Weber KT: Endothelial cell induced modulation of cardiac fibroblast collagen metabolism. Cardiovasc Res. 1993, 27 (6): 1004-1008. 10.1093/cvr/27.6.1004.
Villanueva AG, Farber HW, Rounds S, Goldstein RH: Stimulation of fibroblast collagen and total protein formation by an endothelial cell-derived factor. Circ Res. 1991, 69 (1): 134-141.
Sano H, Tomita K, Hitsuda Y: Expression of vascular cell adhesion molecule-1 on human pulmonary artery endothelial cells and human umbilical vein endothelial cells stimulated by tumor necrosis factor-α, interleukin-1β and lipopolysaccharide. Yonago Acta Medica. 1997, 40: 21-30.
Peng J, Gurantz D, Tran V, Cowling RT, Greenberg BH: Tumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis. Circ Res. 2002, 91 (12): 1119-1126. 10.1161/01.RES.0000047090.08299.D5.
Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, Mann DL: Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation. 1997, 95 (5): 1247-1252.
Nian M, Lee P, Khaper N, Liu P: Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004, 94 (12): 1543-1553. 10.1161/01.RES.0000130526.20854.fa.
Sano I, Kusachi S, Murakami T, Ninomiya Y, Oka T, Nunoyama H, Kumashiro H, Iwabu A, Ueta J, Tsuji T: OPC- a quinoline derivative, counteracts the reduction in type III collagen mRNA due to lipopolysaccharides in cultured rat cardiac fibroblasts. Jpn Heart J. 8212, 42 (1): 125-134. 10.1536/jhj.42.125.
Siwik DA, Chang DL, Colucci WS: Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res. 2000, 86 (12): 1259-1265.
Balligand JL, Cannon PJ: Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. Arterioscler Thromb Vasc Biol. 1997, 17 (10): 1846-1858.
Lau YT, Ma WC: Nitric oxide inhibits migration of cultured endothelial cells. Biochem Biophys Res Commun. 1996, 221 (3): 670-674. 10.1006/bbrc.1996.0654.
Rizvi MA, Myers PR: Nitric oxide modulates basal and endothelin-induced coronary artery vascular smooth muscle cell proliferation and collagen levels. J Mol Cell Cardiol. 1997, 29 (7): 1779-1789. 10.1006/jmcc.1996.0480.
Sarkar R, Webb RC, Stanley JC: Nitric oxide inhibition of endothelial cell mitogenesis and proliferation. Surgery. 1995, 118 (2): 274-279. 10.1016/S0039-6060(05)80334-4.
Myers PR, Tanner MA: Vascular endothelial cell regulation of extracellular matrix collagen: role of nitric oxide. Arterioscler Thromb Vasc Biol. 1998, 18 (5): 717-722.
Chao CC, Hu S, Sheng WS, Tsang M, Peterson PK: Tumor necrosis factor-alpha mediates the release of bioactive transforming growth factor-beta in murine microglial cell cultures. Clin Immunol Immunopathol. 1995, 77 (3): 358-365. 10.1006/clin.1995.1163.
Chagnon F, Metz CN, Bucala R, Lesur O: Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ Res. 2005, 96: 1095-1102. 10.1161/01.RES.0000168327.22888.4d.
Kruger S, Kunz D, Graf J, Stickel T, Merx MW, Koch KC, Janssens U, Hanrath P: Endotoxin hypersensitivity in chronic heart failure. Int J Cardiol. 2007, 115 (2): 159-163. 10.1016/j.ijcard.2006.03.003.
Chan EL, Haudek SB, Giroir BP, Murphy JT: Human coronary endothelial cell activation by endotoxin is characterized by NF-kappa B activation and TNF-alpha synthesis. Shock. 2001, 16 (5): 349-354. 10.1097/00024382-200116050-00005.
The authors acknowledge the Department of Science and Technology, Government of India, for financial assistance and the Director of the Institute for facilities.
The authors declare that they have no competing interests.
LK participated in the design of the study, carried out the tissue culture experiments, various assays, performed the statistical analysis and drafted the manuscript. CCK conceived of the study, participated in its design, participated in the writing of the manuscript and coordinated the study. Both authors read and approved the final manuscript.
About this article
Cite this article
Kuruvilla, L., Kartha, C.C. Treatment with TNF-α or bacterial lipopolysaccharide attenuates endocardial endothelial cell-mediated stimulation of cardiac fibroblasts. J Biomed Sci 16, 21 (2009). https://doi.org/10.1186/1423-0127-16-21
- Nitric Oxide
- Conditioned Medium
- Collagen Synthesis
- Thymidine Incorporation
- Cardiac Fibroblast